Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy.
Hay, Kevin A
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy. [electronic resource] - Blood 11 2017 - 2295-2306 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1528-0020
10.1182/blood-2017-06-793141 doi
Adult
Aged
Biomarkers, Tumor--metabolism
Blood Coagulation Disorders--complications
Cytokines--metabolism
Endothelial Cells--pathology
Female
Fever--etiology
Hematopoiesis
Hemodynamics
Humans
Immunotherapy, Adoptive
Kinetics
Lymphocyte Count
Male
Middle Aged
Multivariate Analysis
Neurotoxicity Syndromes--complications
Receptors, Antigen, T-Cell--metabolism
Risk Factors
Syndrome
T-Lymphocytes--immunology
Treatment Outcome
Young Adult
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy. [electronic resource] - Blood 11 2017 - 2295-2306 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1528-0020
10.1182/blood-2017-06-793141 doi
Adult
Aged
Biomarkers, Tumor--metabolism
Blood Coagulation Disorders--complications
Cytokines--metabolism
Endothelial Cells--pathology
Female
Fever--etiology
Hematopoiesis
Hemodynamics
Humans
Immunotherapy, Adoptive
Kinetics
Lymphocyte Count
Male
Middle Aged
Multivariate Analysis
Neurotoxicity Syndromes--complications
Receptors, Antigen, T-Cell--metabolism
Risk Factors
Syndrome
T-Lymphocytes--immunology
Treatment Outcome
Young Adult